98%
921
2 minutes
20
Background: A delayed diagnosis of breast cancer (BC) is linked to more advanced stages of the disease and lower survival rates. This study aims to explore the association between personal factors, family and community interactions, awareness of BC and breast self-examination (BSE), and delays in BC diagnosis among patients at the Mohammed VI Oncology Center, Casablanca, Morocco.
Methods: We conducted a cross-sectional study at the Mohammed IV Oncology Center from January 2023 to July 2024. A questionnaire was administered to collect data on sociodemographic and clinical characteristics of participants, personal factors, and community and family interactions, as well as their knowledge about BC and BSE practices. BC stages I and IIa were categorized as "early diagnosis," while stages IIb, IIIa, IIIb, and IV were classified as "delayed diagnosis." A time interval of more than three months was considered delayed. The chi-square test or Fisher's exact test was employed to assess the association between independent variables and outcomes. To examine the impact of the included factors on the interval of time (<3 months or >3 months), binary logistic regression analyses were conducted. Variables achieving statistical significance (p < 0.05) were subsequently included in the final multiple logistic regression models for each outcome.
Results: A total of 436 patients were interviewed, with a majority (65.1%) diagnosed at an advanced stage. The main factors impacting diagnosis interval included the individual's residency in rural or semi-urban areas (OR: 2.01, 95% CI: 1.01-4.00), fear of death (OR: 0.97, 95% CI: 0.95-0.99), fear of total mastectomy (OR: 5.44, 95% CI: 1.39-21.32), distrust in the expertise of institutions (OR: 9.07, 95% CI: 1.52-53.88), and having never heard of BC (OR: 4.79, 95% CI: 1.49-15.41). Conversely, performing BSE (OR: 0.35, 95% CI: 0.12-1.01) was identified as a significant protective factor against delayed diagnosis.
Conclusion: It is crucial to focus on enhancing access to affordable, high-quality healthcare and to promote health literacy related to BC among the general public.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399222 | PMC |
http://dx.doi.org/10.7759/cureus.89191 | DOI Listing |
Crit Rev Immunol
January 2025
Department of General Surgery, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300150, China.
Objective: This study aimed to probe the role of Shenling Baizhu powder (SLBZP) in inhibiting breast cancer (BC) lung metastasis, focusing on epithelial-to-mesenchymal transition (EMT) and ferroptosis.
Methods: BC 4T1 cells were treated with low (3.13 µg/mL) and high (12.
J Environ Pathol Toxicol Oncol
January 2025
Department of General Surgery, Xiangshan First People's Hospital Medical and Health Group, Ningbo 315700, China.
Breast cancer (BC) is one of the main causes of cancer-related death in women. The purpose of this study was to evaluate the expression of miR-605-5p in BC and its diagnostic and prognostic value. BC patients and healthy individuals who met the study criteria were included.
View Article and Find Full Text PDFJ Environ Pathol Toxicol Oncol
January 2025
Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Noncoding RNA regulatory networks play crucial roles in human breast cancer. The aim of this study was to establish a network containing multi-type RNAs and RBPs in triple-negative breast cancer (TNBC). Differential expression analyses of lncRNAs, miRNAs, and genes were performed using the GEO2R tool.
View Article and Find Full Text PDFJ Environ Pathol Toxicol Oncol
January 2025
Department of Clinical Laboratory Medicine, Fujian Medical University, Fuzhou, China.
Invasive ductal carcinoma (IDC) is a major type of breast cancer. The utilization of inhibitors targeting histone methyltransferases introduces novel therapeutic avenues for the treatment of cancer. Immunohistochemistry, Western blot, and reverse transcription quantitative polymerase chain reaction experiments were applied to assess the levels of EHMT2 in IDC and adjacent tissues.
View Article and Find Full Text PDFCrit Rev Ther Drug Carrier Syst
January 2025
Department of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India.
Cancer stem cells (CSCs) are a category of cancer cells endowed with the ability to renew themselves, undergo unregulated growth, and exhibit a differentiation capacity akin to that of normal stem cells. CSCs have been linked with tumor metastasis and cancer recurrence due to their ability to elude immune monitoring. As a result, targeting CSCs specifically may improve the efficacy of cancer therapy.
View Article and Find Full Text PDF